1011 North Galloway Avenue, Mesquite, TX, 75149 · (214) 320-7000
Beds
202
FY 2025
Star rating
3 of 5
Patient survey: 3 of 5
Net patient revenue
$160.3M
FY 2025
Net income
$31.2M
Patient care margin 18.7%
Discharges
7,980
Occupancy 45.3%
Clinicians
174
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $160.3M | $130.3M | 18.7% | $31.2M | 7,980 | $20.8M | 12.9% | 1.9% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 8.3% | US median 8.5% |
| Death rate for heart attack patients | 13% | US median 11.8% |
| Death rate for heart failure patients | 10.7% | US median 11% |
| Hospital-wide death rate within 30 days | 4% | US median 3.9% |
| Death rate for pneumonia patients | 16.8% | US median 15.2% |
| Death rate for stroke patients | 13.7% | US median 11.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $134.4M | $114.5M | 14.9% | $20.9M | 6,900 | $16.3M | 14.7% | 2.1% |
| 2023 | $110.4M | $104.5M | 5.4% | $6.9M | 6,965 | $18.0M | 16.0% | 2.9% |
| 2022 | $106.6M | $104.3M | 2.2% | $2.6M | 6,444 | $17.0M | 17.4% | 2.5% |
| 2021 | $104.1M | $94.2M | 9.5% | $12.3M | 6,299 | $19.9M | 17.6% | 6.6% |
| 2020 | $99.3M | $91.6M | 7.8% | $9.3M | 6,835 | $16.2M | 21.1% | 4.0% |
| Readmission rate for COPD | 19.6% | US median 19.8% |
| Readmission rate after a heart attack | 14.7% | US median 14.4% |
| Readmission rate for heart failure | 21.5% | US median 21.3% |
| Readmission rate for pneumonia | 16.7% | US median 17.2% |
| Serious complications (patient safety composite) | 1.13 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.32 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.43 | US median 0.48 |
| MRSA bloodstream infections (ratio to expected) | 0.00 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.32 | US median 0.40 |
| Doctors always communicated well | 75% | US median 79% |
| Nurses always communicated well | 72% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 58% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 64% | US median 72% |
| Room and bathroom always clean | 70% | US median 73% |
| Patients who would definitely recommend the hospital | 63% | US median 71% |
| Patients who left the emergency department before being seen | 3% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 166 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 12% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 65% | US median 65% |
| Healthcare workers given the flu vaccine | 72% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 82% | US median 74% |
| 33 |
| $70,480.12 |
| $9,291.52 |
| $9,867.73 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 28 | $52,023.25 | $8,979.29 | $9,973.97 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 27 | $53,910.26 | $12,101.26 | $12,667.88 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 26 | $211,929.31 | $33,072.54 | $40,556.82 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 22 | $59,083.86 | $9,544.77 | $10,642.23 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 21 | $33,108.33 | $5,980.90 | $5,662.18 |
| DRG 321 PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITH MCC OR 4+ ARTERIES/ | 19 | $168,018.37 | $17,471.84 | $22,190.93 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 19 | $62,242.58 | $12,136.84 | $13,076.55 |
| DRG 312 SYNCOPE AND COLLAPSE | 17 | $50,880.29 | $6,228.47 | $6,636.32 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 17 | $41,097.06 | $9,070.00 | $8,838.11 |
| DRG 641 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | 16 | $28,968.75 | $6,038.56 | $5,829.71 |
| DRG 870 SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | 15 | $258,983.87 | $44,959.27 | $58,777.93 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 14 | $61,544.50 | $12,391.79 | $12,400.10 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5302 Level 2 Upper GI Procedures | 18 | 18 | $1,283.26 | $1,444.50 |
| APC 5191 Level 1 Endovascular Procedures | 17 | 17 | $2,108.01 | $2,207.96 |
| APC 5183 Level 3 Vascular Procedures | 14 | 14 | $2,285.43 | $2,405.01 |
| APC 8011 Comprehensive Observation Services | 14 | 14 | $1,962.60 | $2,090.36 |
| APC 5414 Level 4 Gynecologic Procedures | - | - | - | $2,389.24 |
| APC 5331 Complex GI Procedures | - | - | - | $4,262.70 |
| APC 5184 Level 4 Vascular Procedures | - | - | - | $3,945.82 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | - | - | - | $1,219.56 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | - | - | - | $2,141.49 |
| APC 5112 Level 2 Musculoskeletal Procedures | - | - | - | $1,196.16 |
| APC 5113 Level 3 Musculoskeletal Procedures | - | - | - | $2,373.24 |
| APC 5114 Level 4 Musculoskeletal Procedures | - | - | - | $5,338.75 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Dallas Regional Medical Center is a for-profit short-term acute care hospital in Mesquite, TX with 202 beds, part of Prime Healthcare and a 3-star overall rating.
Dallas Regional Medical Center in Mesquite, TX has 202 beds (fiscal year 2025 cost report); 172 beds are certified for Medicare. It discharged 7,980 inpatients that year, with 45.3% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Dallas Regional Medical Center reported net patient revenue of $160.3M and operating expenses of $130.3M, a margin on patient care of 18.7%. After other income and expenses its net income was $31.2M (19.3% of revenue), so it made a profit that year.
Dallas Regional Medical Center is part of Prime Healthcare, a health system with 47 hospitals based in Ontario, CA. It is a for-profit hospital.
Dallas Regional Medical Center has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey.
Yes, Dallas Regional Medical Center provides emergency services.
174 Medicare clinicians list Dallas Regional Medical Center as a hospital they work at, most often in Internal Medicine, Orthopedic Surgery, Diagnostic Radiology.
In 2024, Dallas Regional Medical Center had 501 Medicare inpatient stays in 17 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 132 stays; Medicare paid $14,030.02 per stay on average, compared with $15,524.21 across all hospitals.